AstraZeneca investors raise concerns over mega-merger talks
- Posted on August 3, 2026
- By Financial Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca investors raise concerns over mega-merger talks
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
